Nabil Adam - Vice provost for Research, Rutgers Newark
Dr. Adam, a branch chief from the U.S. Department of Homeland Security, currently serves as the Vice-Provost for research at Rutgers University - Newark. His research work has been supported by over $18 million from numerous federal and state agencies, including: Department of Homeland Security, the National Science Foundation, the National Security Agency, National oceanic and Atmospheric Administration, the U.S. Environmental Protection Agency, the National Library of Medicine, the New Jersey Meadowlands Commission, and NASA. Dr. Adam also served as a Senior Program Manager, managed the Complex Event Modeling, Simulation, and Analysis program, and served as the technical lead for the Unified Incident Command & Decision Support System program during his time with Homeland Security.
Yana Bromberg, Asst Professor - SEBS
Yana Bromberg is an assistant professor in the Department of Biochemistry and Microbiology. She has a Ph.D in Biomedical Informatics from Columbia University and a bachelors degree in both biology and computer science from Stony Brook State University. Her specific research interests include developing methods for fast, accurate, and meaningful ways of analyzing biological data. She has also collaborated with Burkhard Rost, head of the Unit for Computational Biology & Bioinformatics at the Department of Informatics of the Technical University of Munich (TUM).
Stephen Burley, Director, CIPR
Stephen K. Burley serves as the director for the Center for Integrative Proteomics Research. He is an expert in structural biology and proteomics, structure/fragment based drug discovery, and clinical medicine/oncology. He is also a member of the Cancer Institute of New Jersey. Prior to joining Rutgers University, Dr. Burley served as a distinguished Lilly Research Scholar in the Lilly Research Laboratories. He was also the chief scientific officer of SGX Pharmaceuticals, Inc., an oncology-focused drug discovery and development company located in California. Burley received an M.D. degree from Harvard Medical School in the joint Harvard-MIT Health Sciences and Technology program, and as a Rhodes Scholar, received a D.Phil. in Molecular Biophysics from Oxford University.
Richard Falk, Professor of Mathematics, SAS
A professor since 1972, Richard S. Falk currently teaches mathematics for Rutgers University and served as acting executive dean of the School of Arts and Sciences (SAS) from July 2012 through June 2014. He is a past chair of the university-wide Committee on Academic Planning and Review (CAPR), and has been acting chair or chair of the SAS Department of Mathematics on several occasions. His many years as a faculty member, plus his experience in leadership positions makes him uniquely qualified for any position.
Thomas Farris, Dean, SOE
Thomas Farris is the Dean of the School of Engineering at Rutgers University and a member of the Materials Technical Committee of the AIAA. Prior to Rutgers, Farris joined Purdue University as an assistant professor in 1986 and was appointed to school head in 1988. During his tenure there, he had an active research interest in aerospace structures and materials with a focus on tribology, manufacturing process, and fatigue and fracture. He has been acknowledged for research by an NSF Presidential Young Investigator Award, a Japan Society for the Promotion of Science Fellowship, the ASME/Boeing Structures and Materials Award for outstanding paper of 1998 SDM, the journal of Strain Analysis P E Publishing Award in 2002, and the ASME’s Burt L. Newkirk Award. Farris received a B.S.M.E. in 1982 from Rice University and a Ph.D. in Applied Mechanics at Northwestern University in 1986.
Shridar Ganesan, Medical Oncologist, RU CINJ
Shridar Ganesan came to The Cancer Institute of New Jersey (CINJ) in 2005 from the Dana-Farber Cancer Institute/Harvard Medical School where he was both an instructor in medicine and staff physician. With a research interest in breast cancer biology and DNA repair, he is currently exploring how DNA repair defects in cancers can be exploited to develop novel effective treatments. Ganesan also runs a basic research laboratory focused on breast cancer biology and sees patients in the Stacy Goldstein Breast Cancer Center. He is the author/co-author of more than 40 publications and serves on the editorial board of the Journal Frontiers in Molecular and Cellular Oncology.
David Kimball, Associate VP, Translational Research
David Kimball is a research professor in the Ernest Mario School of Pharmacy, and has recently been appointed as the first associate vice president for translational science in the Office of the Vice President for Research and Economic Development. Kimball earned his doctorate in organic chemistry and chemical biology from Stony Brook University in 1982 and relocated to New Jersey, where he became a research fellow at Bristol-Myers Squibb. Kimball’s research has focused on the discovery of novel small molecule treatments for human diseases, spanning cardiovascular disease, metabolic disease, inflammation, oncology, neuroscience, and pain. His current interests include the role of Apolipoprotein E (ApoE) in Alzheimer’s disease and traumatic brain injury and the structure-based design of kinase inhibitors for cancer and inflammatory disease.
Christopher J. Molloy, Senior VP, ORED
Christopher J. Molloy joined Rutgers University in 2007 as dean of the Ernest Mario School of Pharmacy. Since then, he was appointed to interim provost for biomedical and health sciences and successfully managed the integration of Rutgers University and most of UMDNJ. He became the University’s senior vice president for Research and Economic Development and currently oversees the strategic planning for the university’s $700 million in annual research expenditures and management of the many offices and resources the support ORED’s activities. Molloy received his bachelor’s degree in pharmacy from Rutgers and his doctoral degree from the joint Rutgers Graduate School of Biomedical Sciences at Robert Wood Johnson Medical School/Graduate School - New Brunswick.
Benedetto Piccoli, Director, CCIB, Rutgers Camden
Benedetto Piccoili serves as the director at the Center of Computational and Integrative Biology (CCIB). He received the Chancellor’s Award for Teaching Excellence in 2013 and has conducted research on network traffic flow, numerics and applications, ode and pde models, pde methods for signal analysis, applications of optimal control to biological systems, bio-mechanical systems, and much more.
Ron Ransome, Area Dean for MPS, SAS
As an Area Dean since 2013, Ron Ransome maintains oversight over both undergraduate and graduate instruction within departments and programs. He is also an experimental nuclear physicists with a research emphasis on studies of the internal structure of the nucleon using neutrinos and electrons as probes. Since joining Rutgers in 1985, he served as graduate director from 2005-2010 and as chair from 2010-2013 for the Physics Department.
Fred Roberts, Director, CCIDADA
Fred Roberts is the Director of Command, Control and Interoperability Center for Advanced Data Analysis (CCICADA), Fred S. Roberts conducts research on mathematical models applied to homeland security, social, behavioral, biological, and environmental sciences. Roberts has authored books on these subjects and has been published in over 160 professional journals, recently appearing in Discrete Applied Mathematics, IEEE Press, Annals of Operation Research, and the Society for Industrial and Applied Mathematics. Roberts was also awarded the Daniel Webster National Scholar award in 1961. In 2006, he received the Burroughs Welcome Fund Grant. Roberts received his Ph.D. in mathematics from Stanford University in 1968.
Rachel Somerville, Professor, SAS
Having joined Rutgers University in July 2011, Rachel Somerville was appointed the inaugural holder of the George A. and Margaret M. Downsbrough Chair in Astrophysics. She is currently a professor in the Department of Physics and Astronomy. Dr. Somerville is also a member of the Great Observatories Origins Deep Survey (GOODS) team to survey the formation and evolution of galaxies in the early universe. She leads the theoretical group of the Cosmuc Assembly Near-infrared Deep Extragalactic Legacy Survey (CANDELS), the largest project yet with the Hubble Space Telescope and she is recognized for creating computer simulations of the physics underlying galaxy formation and evolution.
Jay Tischfield, CEO and Scientific Director, RUCDR
As Founder, CEO and Scientific Director, Jay A. Tischfield is responsible for the scientific direction, funding and overall mission of RUCDR Infinite Biologics. His over 200 publications describe the genetics of severe combined immunodeficiency disease, inherited kidney stone diseases, alcoholism, limb-girdle muscular dystrophy, autism and Tourette syndrome, as well as basic science related to our understanding of genetic stability in somatic and pluripotent stem cells. His experience in organizing, leading and executing large scale projects involving hundreds of thousands of human subjects provides the background expertise for RUCDR Infinite Biologics. Dr. Tischfield has ranked among the top five percent of National Institutes of Health-funded researchers for over 35 years, with over $250 million in total funding.